Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
St. Jude Medical touts clinical findings in support of its Genesis peripheral nerve stimulation implant in helping patients with chronic migraines.
Medtronic said the 1st phase of a small trial of the next iteration of its Symplicity device for treating high blood pressure showed a 100% success rate.
Edwards Lifesciences’ transcatheter aortic valve implantation systems proves effective in the 1st reports from a global registry of TAVI patients, but safety issues raise eyebrows.